Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$6.67 - $9.71 $2.09 Million - $3.05 Million
314,025 Added 24.17%
1,613,516 $10.8 Million
Q2 2023

Aug 14, 2023

SELL
$6.86 - $10.86 $13.1 Million - $20.7 Million
-1,905,299 Reduced 59.45%
1,299,491 $11.8 Million
Q1 2023

May 15, 2023

SELL
$6.78 - $8.1 $9.69 Million - $11.6 Million
-1,429,012 Reduced 30.84%
3,204,790 $23.3 Million
Q4 2022

Feb 14, 2023

BUY
$5.72 - $9.78 $678,311 - $1.16 Million
118,586 Added 2.63%
4,633,802 $33.8 Million
Q3 2022

Nov 14, 2022

BUY
$7.24 - $10.31 $32.7 Million - $46.6 Million
4,515,216 New
4,515,216 $34.9 Million

Others Institutions Holding PNT

# of Institutions
1
Shares Held
20K
Call Options Held
0
Put Options Held
0

About POINT Biopharma Global Inc.


  • Ticker PNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 104,025,000
  • Description
  • POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...
More about PNT
Track This Portfolio

Track Pfm Health Sciences, LP Portfolio

Follow Pfm Health Sciences, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfm Health Sciences, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pfm Health Sciences, LP with notifications on news.